Differential acetylation of Tat coordinates its interaction with the co-activators cyclin T1 and PCAF

EMBO Journal

Volumn 21, Issue 24, 2002, Pages 6811-6819

  Brès, Vanessa ^a   Tagami, Hideaki ^e   Péloponèse, Jean Marie ^b,d   Loret, Erwan ^b   Jeang, Kuan Teh ^d   Nakatani, Yoshihiro ^e   Emiliani, Stephane ^c   Benkirane, Monsef ^a   Kiernan, Rosemary E ^a  

^a INSTITUTE OF HUMAN GENETICS   (France)

^b CNRS   (France)

^c INSTITUT COCHIN   (France)

^d NATIONAL INSTITUTE OF ALLERGY AND INFECTIOUS DISEASES   (United States)

^e DANA FARBER CANCER INSTITUTE   (United States)

Author keywords

Cyclin T1; Differential acetylation; HIV 1; PCAF; Tat

Indexed keywords

BINDING PROTEIN; CYCLIN T1; HISTONE ACETYLTRANSFERASE; HISTONE ACETYLTRANSFERASE PCAF; LYSINE; PROTEIN P300; PROTEIN TEFB; RNA; TRANSACTIVATOR PROTEIN; UNCLASSIFIED DRUG;

ACETYLATION; ARTICLE; BINDING SITE; COMPLEX FORMATION; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HUMAN IMMUNODEFICIENCY VIRUS 1; LONG TERMINAL REPEAT; NONHUMAN; PRIORITY JOURNAL; PROTEIN BINDING; PROTEIN PROTEIN INTERACTION;

ACETYLATION; ACETYLTRANSFERASES; BLOTTING, WESTERN; CELL CYCLE PROTEINS; CHROMATOGRAPHY, AFFINITY; CYCLINS; GENE PRODUCTS, TAT; GLUTATHIONE TRANSFERASE; HELA CELLS; HISTONE ACETYLTRANSFERASES; HIV LONG TERMINAL REPEAT; HUMANS; LYSINE; MODELS, BIOLOGICAL; NUCLEAR PROTEINS; PEPTIDES; PROTEIN BINDING; RECOMBINANT FUSION PROTEINS; TRANS-ACTIVATION (GENETICS); TRANS-ACTIVATORS; TRANSCRIPTION FACTORS;

HUMAN IMMUNODEFICIENCY VIRUS; HUMAN IMMUNODEFICIENCY VIRUS 1;

EID: 12244271066     PISSN: 02614189     EISSN: None     Source Type: Journal    
DOI: 10.1093/emboj/cdf669     Document Type: Article

References (55)

1. Ait-Si-Ali, S. et al. (1998) Histone acetyltransferase activity of CBP is controlled by cycle-dependent kinases and oncoprotein E1A. Nature, 396, 184-186.
2. Barany, G. and Merrifield, R.B. (1979) The peptide. In Gross, E. and Meinhofer, J. (eds), Solid phase peptide synthesis, Vol. 2. Academic Press, New York, NY, pp. 1-284.
3. Beckett, D. (2001) Regulated assembly of transcription factors and control of transcription initiation. J. Mol. Biol., 314, 335-352.
4. Benkirane, M., Chun, R.F., Xiao, H., Ogryzko, V.V., Howard, B.H., Nakatani, Y. and Jeang, K.T. (1998) Activation of integrated provirus requires histone acetyltransferase. p300 and P/CAF are coactivators for HIV-1 Tat. J. Biol. Chem., 273, 24898-24905.
5. Berkhout, B., Silverman, R.H. and Jeang, K.T. (1989) Tat trans-activates the human immunodeficiency virus through a nascent RNA target. Cell, 59, 273-282.
6. Bieniasz, P.D., Grdina, T.A., Bogerd, H.P. and Cullen, B.R. (1999) Recruitment of cyclin T1/P-TEFb to an HIV type 1 long terminal repeat promoter proximal RNA target is both necessary and sufficient for full activation of transcription. Proc. Natl. Acad. Sci. USA, 96, 7791-7796.
7. Bres, V., Kiernan, R.E., Emiliani, S. and Benkirane, M. (2002) Tat acetylacceptor lysines are important for human immunodeficiency virus type-1 replication. J. Biol. Chem., 277, 22215-22221.
8. Chen, D., Fong, Y. and Zhou, Q. (1999) Specific interaction of Tat with the human but not rodent P-TEFb complex mediates the speciesspecific Tat activation of HIV-1 transcription. Proc. Natl. Acad. Sci. USA, 96, 2728-2733.
9. Cho, H., Orphanides, G., Sun, X., Yang, X.J., Ogryzko, V., Lees, E., Nakatani, Y. and Reinberg, D. (1998) A human RNA polymerase II complex containing factors that modify chromatin structure. Mol. Cell. Biol., 18, 5355-5363.
10. Chun, R.F. and Jeang, K.T. (1996) Requirements for RNA polymerase II carboxyl-terminal domain for activated transcription of human retroviruses human T-cell lymphotropic virus I and HIV-1. J. Biol. Chem., 271, 27888-27894.
11. Clavel, F. and Charneau, P. (1994) Fusion from without directed by human immunodeficiency virus particles. J. Virol., 68, 1179-1185.
12. Col, E., Caron, C., Seigneurin-Berny, D., Gracia, J., Favier, A. and Khochbin, S. (2001) The histone acetyltransferase, hGCN5, interacts with and acetylates the HIV transactivator, Tat. J. Biol. Chem., 276, 28179-28184.
13. Cujec, T.P., Cho, H., Maldonado, E., Meyer, J., Reinberg, D. and Peterlin, B.M. (1997) The human immunodeficiency virus transactivator Tat interacts with the RNA polymerase II holoenzyme. Mol. Cell. Biol., 17, 1817-1823.
14. Deng, L. et al. (2000) Acetylation of HIV-1 Tat by CBP/P300 increases transcription of integrated HIV-1 genome and enhances binding to core histones. Virology, 277, 278-295.
15. Dingwall, C. et al. (1989) Human immunodeficiency virus 1 tat protein binds trans-activation-responsive region (TAR) RNA in vitro. Proc. Natl. Acad. Sci. USA, 86, 6925-6929.
16. Fujinaga, K., Cujec, T.P., Peng, J., Garriga, J., Price, D.H., Grana, X. and Peterlin, B.M. (1998) The ability of positive transcription elongation factor B to transactivate human immunodeficiency virus transcription depends on a functional kinase domain, cyclin T1 and Tat. J. Virol., 72, 7154-7159.
17. Garber, M.E., Wei, P., KewalRamani, V.N., Mayall, T.P., Herrmann, C.H., Rice, A.P., Littman, D.R. and Jones, K.A. (1998) The interaction between HIV-1 Tat and human cyclin T1 requires zinc and a critical cysteine residue that is not conserved in the murine CycT1 protein. Genes Dev., 12, 3512-3527.
18. Herrmann, C.H. and Rice, A.P. (1993) Specific interaction of the human immunodeficiency virus Tat proteins with a cellular protein kinase. Virology, 197, 601-608.
19. Herrmann, C.H. and Rice, A.P. (1995) Lentivirus Tat proteins specifically associate with a cellular protein kinase, TAK, that hyperphosphorylates the carboxyl-terminal domain of the large subunit of RNA polymerase II: Candidate for a Tat cofactor. J. Virol., 69, 1612-1620.
20. Hottiger, M.O. and Nabel, G.J. (1998) Interaction of human immunodeficiency virus type 1 Tat with the transcriptional coactivators p300 and CREB binding protein. J. Virol., 72, 8252-8256.
21. Ivanov, D., Kwak, Y.T., Nee, E., Guo, J., Garcia-Martinez, L.F. and Gaynor, R.B. (1999) Cyclin T1 domains involved in complex formation with Tat and TAR RNA are critical for tat-activation. J. Mol. Biol., 288, 41-56.
22. Jeang, K.T., Xiao, H. and Rich, E.A. (1999) Multifaceted activities of the HIV-1 transactivator of transcription, Tat. J. Biol. Chem., 274, 28837-28840.
23. Jones, K.A. (1997) Taking a new TAK on tat transactivation. Genes Dev., 11, 2593-2599.
24. Kawasaki, H., Schiltz, L., Chiu, R., Itakura, K., Taira, K., Nakatani, Y. and Yokoyama, K.K. (2000) ATF-2 has intrinsic histone acetyltransferase activity which is modulated by phosphorylation. Nature, 405, 195-200.
25. Kieman, R.E. et al. (1999) HIV-1 tat transcriptional activity is regulated by acetylation. EMBO J., 18, 6106-6118.
26. Mancebo, H.S. et al. (1997) P-TEFb kinase is required for HIV Tat transcriptional activation in vivo and in vitro. Genes Dev., 11, 2633-2644.
27. Marciniak, R.A. and Sharp, P.A. (1991) HIV-1 Tat protein promotes formation of more-processive elongation complexes. EMBO J., 10, 4189-4196.
28. Marshall, N.F. and Price, D.H. (1992) Control of formation of two distinct classes of RNA polymerase II elongation complexes. Mol. Cell. Biol., 12, 2078-2090.
29. Marshall, N.F. and Price, D.H. (1995) Purification of P-TEFb, a transcription factor required for the transition into productive elongation. J. Biol. Chem., 270, 12335-12338.
30. Marzio, G., Tyagi, M., Gutierrez, M.I. and Giacca, M. (1998) HIV-1 tat transactivator recruits p300 and CREB-binding protein histone acetyltransferases to the viral promoter. Proc. Natl. Acad. Sci. USA. 95, 13519-13524.
31. Mujtaba, S., He, Y., Zeng, L., Farooq, A., Carlson, J.E., Ott, M., Verdin, E. and Zhou, M.M. (2002) Structural basis of lysine-acetylated HIV-1 Tat recognition by PCAF bromodomain. Mol. Cell, 9, 575-586.
32. Munshi, N., Merika, M., Yie, J., Senger, K., Chen, G. and Thanos, D. (1998) Acetylation of HMG I(Y) by CBP turns off 1FNβ expression by disrupting the enhanceosome. Mol. Cell, 2, 457-467.
33. Munshi, N., Agalioti, T., Lomvardas, S., Merika, M., Chen, G. and Thanos, D. (2001) Coordination of a transcriptional switch by HMGI(Y) acetylation. Science, 293, 1133-1136.
34. Nakatani, Y. (2002) HIV-1 transcription. Activation mediated by acetylation of Tat. Structure (Camb), 10, 443-444.
35. Ogryzko, V.V., Schiltz, R.L., Russanova, V., Howard, B.H. and Nakatani, Y. (1996) The transcriptional coactivators p300 and CBP are histone acetyltransferases. Cell, 87, 953-959.
36. Ogryzko, V.V., Kotani, T., Zhang, X., Schiltz, R.L., Howard, T., Yang, X.J., Howard, B.H., Qin, J. and Nakatani, Y. (1998) Histone-like TAFs within the PCAF histone acetylase complex. Cell, 94, 35-44.
37. Okamoto, H., Sheline, C.T., Corden, J.L., Jones, K.A. and Peterlin, B.M. (1996) Trans-activation by human immunodeficiency virus Tat protein requires the C-terminal domain of RNA polymerase II. Proc. Natl. Acad. Sci. USA, 93, 11575-11579.
38. Ott, M., Schnolzer, M., Garnica, J., Fischle, W., Emiliani, S., Rackwitz, H.R. and Verdin, E. (1999) Acetylation of the HIV-1 Tat protein by p300 is important for its transcriptional activity. Curr. Biol., 9, 1489-1492.
39. Parada, C.A. and Roeder, R.G. (1996) Enhanced processivity of RNA polymerase II triggered by Tat-induced phosphorylation of its carboxy-terminal domain. Nature, 384, 375-378.
40. Peloponese, J.M., Jr, Collette, Y., Gregoire, C., Bailly, C., Campese, D., Meurs, E.F., Olive, D. and Loret, E.P. (1999) Full peptide synthesis, purification and characterization of six Tat variants. Differences observed between HIV-1 isolates from Africa and other continents. J. Biol. Chem., 274, 11473-11478.
41. Peng, J., Zhu, Y., Milton, J.T. and Price, D.H. (1998) Identification of multiple cyclin subunits of human P-TEFb. Genes Dev., 12, 755-762.
42. Roth, S.Y., Denu, J.M. and Allis, C.D. (2001) Histone acetyltransferases. Annu. Rev. Biochem., 70, 81-120.
43. Sheridan, P.L., Sheline, C.T., Cannon, K., Voz, M.L., Pazin, M.J., Kadonaga, J.T. and Jones, K.A. (1995) Activation of the HIV-1 enhancer by the LEF-1 HMG protein on nucleosome-assembled DNA in vitro. Genes Dev., 9, 2090-2104.
44. Sheridan, P.L., Mayall, T.P., Verdin, E. and Jones, K.A. (1997) Histone acetyltransferases regulate HIV-1 enhancer activity in vitro. Genes Dev., 11, 3327-3340.
45. Sterner, D.E. and Berger, S.L. (2000) Acetylation of histones and transcription-related factors. Microbiol. Mol. Biol. Rev., 64, 435-459.
46. Struhl, K. (1998) Histone acetylation and transcriptional regulatory mechanisms. Genes Dev., 12, 599-606.
47. Taube, R., Lin, X., Irwin, D., Fujinaga, K. and Peterlin, B.M. (2002) Interaction between P-TEFb and the C-terminal domain of RNA polymerase II activates transcriptional elongation from sites upstream or downstream of target genes. Mol. Cell. Biol., 22, 321-331.
48. Van Lint, C., Emiliani, S., Ott, M. and Verdin, E. (1996a) Transcriptional activation and chromatin remodeling of the HIV-1 promoter in response to histone acetylation. EMBO J., 15, 1112-1120.
49. Van Lint, C., Emiliani, S. and Verdin, E. (1996b) The expression of a small fraction of cellular genes is changed in response to histone hyperacetylation. Gene Expr., 5, 245-253.
50. Verdin, E., Paras, P., Jr and Van Lint, C. (1993) Chromatin disruption in the promoter of human immunodeficiency virus type 1 during transcriptional activation. EMBO J., 12, 3249-3259.
51. Wei, P., Garber, M.E., Fang, S.M., Fischer,W.H. and Jones, K.A. (1998) A novel CDK9-associated C-type cyclin interacts directly with HIV-1 Tat and mediates its high-affinity, loop-specific binding to TAR RNA. Cell, 92, 451-462.
52. Xiao, H., Lis, J.T. and Jeang, K.T. (1997) Promoter activity of Tat at steps subsequent to TATA-binding protein recruitment. Mol. Cell. Biol., 17, 6898-6905.
53. Yang, X., Herrmann, C.H. and Rice, A.P. (1996) The human immunodeficiency virus Tat proteins specifically associate with TAK in vivo and require the carboxyl-terminal domain of RNA polymerase II for function. J. Virol., 70, 4576-4584.
54. Yang, X., Gold, M.O., Tang, D.N., Lewis, D.E., Aguilar-Cordova, E., Rice, A.P. and Herrmann, C.H. (1997) TAK, an HIV Tat-associated kinase, is a member of the cyclin-dependent family of protein kinases and is induced by activation of peripheral blood lymphocytes and differentiation of promonocytic cell lines. Proc. Natl. Acad. Sci. USA, 94, 12331-12336.
55. Zhu, Y., Pe'ery, T., Peng, J., Ramanathan, Y., Marshall, N., Marshall, T., Amendt, B., Mathews, M.B. and Price, D.H. (1997) Transcription elongation factor P-TEFb is required for HIV-1 tat transactivation in vitro. Genes Dev., 11, 2622-2632.